rugby hemorrhoidal

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: rugby hemorrhoidal
Generic name: COCOA BUTTER, PHENYLEPHRINE HCL
Manufacturer: Rugby Laboratories
Product type: HUMAN OTC DRUG
SPL set ID: c1a126b5-0d34-437f-a7ef-8d5cbeb7b03b
SPL ID: 8abe2b3e-bfd7-4f76-9aa1-5eb375146909
Version: 2
Effective date: 2024-10-22
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:14:16

Harmonized routes table
Harmonized routes
RECTAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		rugby hemorrhoidal	openfda.brand_name
generic name		COCOA BUTTER, PHENYLEPHRINE HCL	openfda.generic_name
manufacturer name		Rugby Laboratories	openfda.manufacturer_name
ndc	package	0536-1186-12	openfda.package_ndc
ndc	product	0536-1186	openfda.product_ndc
ndc11	package	00536118612	derived:openfda.package_ndc
spl id		8abe2b3e-bfd7-4f76-9aa1-5eb375146909	id
spl set id		c1a126b5-0d34-437f-a7ef-8d5cbeb7b03b	set_id
unii		512OYT1CRR	openfda.unii
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For rectal use only Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. When using this product do not exceed the recommended daily dosage unless directed by a doctor Stop use and ask a doctor if • bleeding occurs • condition worsens or does not improve within 7 days If pregnant or breast feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.